Inventor · disambiguated record
Meghan Drummond Samuelson
Also filed as: DRUMMOND SAMUELSON MEGHAN
7 granted patents·11 pending applications·4 citations·filing 2020–2025
75Inventor score
Top patents by PatentIndex Score
18 records- 0188US12252520B2Myosin 15 promoters and uses thereofDECIBEL THERAPEUTICS INC·Filed 2021·Granted Mar 18, 2025·2 cites·13 claims
- 0284US11674177B2Kelch domain containing 7B (KLHDC7B) variants and uses thereofREGENERON PHARMA·Filed 2021·Granted Jun 13, 2023·1 cites·10 claims
- 0381US12258627B2Kelch domain containing 7B (KLHDC7B) variants and uses thereofREGENERON PHARMA·Filed 2023·Granted Mar 25, 2025·0 cites·19 claims
- 0480US11470828B2Rodent model of mood disordersREGENERON PHARMA·Filed 2020·Granted Oct 18, 2022·1 cites·24 claims
- 0572US2025250631A1Kelch Domain Containing 7B (KLHDC7B) Variants And Uses ThereofREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 0670US2023123787A1Rodent model of mood disordersREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 0769US12010979B2Non-human animals comprising a humanized TTR locus and methods of useREGENERON PHARMA·Filed 2022·Granted Jun 18, 2024·0 cites·13 claims
- 0865US12410442B2Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systemsDECIBEL THERAPEUTICS INC·Filed 2021·Granted Sep 9, 2025·0 cites·19 claims
- 0963US2022064735A1Synaptojanin 2 (SYNJ2) Variants And Uses ThereofREGENERON PHARMA·Filed 2021·Application pending·0 cites
- 1060US2025304637A1Myosin 15 promoters and uses thereofDECIBEL THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1159US2025127928A1Gjb2 regulatory elements and uses thereofDECIBEL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1258US2024401079A1Stereocilin promoters and uses thereofDECIBEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1357US2020370119A1Synaptojanin 2 (SYNJ2) Variants And Uses ThereofREGENERON PHARMA·Filed 2020·Application pending·0 cites
- 1454US2024002839A1Crispr sam biosensor cell lines and methods of use thereofDECIBEL THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1553US2021300976A1Fascin-2 (FSCN2) Variants And Uses ThereofREGENERON PHARMA·Filed 2021·Application pending·0 cites
- 1651US2021371930A1Solute Carrier Family 26 Member 5 (SLC26A5) Variants And Uses ThereofREGENERON PHARMA·Filed 2021·Application pending·0 cites
- 1750US11891618B2Mouse comprising a humanized TTR locus with a beta-slip mutation and methods of useREGENERON PHARMA·Filed 2020·Granted Feb 6, 2024·0 cites·28 claims
- 1848US2023102342A1Non-human animals comprising a humanized ttr locus comprising a v30m mutation and methods of useREGENERON PHARMA·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →